LMAT
Lemaitre Vascular Inc

506
Mkt Cap
$2.1B
Volume
172,563.00
52W High
$109.58
52W Low
$71.42
PE Ratio
37.35
LMAT Fundamentals
Price
$84.44
Prev Close
$86.60
Open
$87.51
50D MA
$88.41
Beta
0.79
Avg. Volume
113,875.65
EPS (Annual)
$1.93
P/B
5.20
Rev/Employee
$331,118.98
Loading...
Loading...
News
all
press releases
LeMaitre Vascular, Inc. $LMAT Shares Sold by ProShare Advisors LLC
ProShare Advisors LLC cut its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 13.9% in the second quarter, according to its most recent disclosure with the SEC. The firm...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
New Strong Buy Stocks for November 14th
NPSNY, SUZ, EVCM, LMAT and TER have been added to the Zacks Rank #1 (Strong Buy) List on Nov.14, 2025
Zacks·7d ago
News Placeholder
3 Reasons Why Growth Investors Shouldn't Overlook LeMaitre (LMAT)
LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks·9d ago
News Placeholder
Roth Capital Has Bullish Forecast for LMAT FY2025 Earnings
LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) - Equities research analysts at Roth Capital boosted their FY2025 EPS estimates for LeMaitre Vascular in a research report issued to clients and...
MarketBeat·11d ago
News Placeholder
LeMaitre Vascular (NASDAQ:LMAT) Price Target Lowered to $93.00 at Wells Fargo & Company
Wells Fargo & Company dropped their price target on shares of LeMaitre Vascular from $97.00 to $93.00 and set an "equal weight" rating on the stock in a research note on Friday...
MarketBeat·12d ago
News Placeholder
LeMaitre Vascular (NASDAQ:LMAT) Issues Earnings Results
LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) released its earnings results on Thursday. The medical instruments supplier reported $0.75 earnings per share for the quarter, topping analysts...
MarketBeat·13d ago
News Placeholder
LeMaitre Vascular (NASDAQ:LMAT) Issues Q4 2025 Earnings Guidance
LeMaitre Vascular (NASDAQ:LMAT) updated its fourth quarter 2025 earnings guidance. The company provided EPS guidance of 0.640-0.690 for the period, compared to the consensus estimate of 0.630. The...
MarketBeat·13d ago
News Placeholder
LeMaitre Vascular (NASDAQ:LMAT) Updates FY 2025 Earnings Guidance
LeMaitre Vascular (NASDAQ:LMAT) updated its FY 2025 earnings guidance. The company provided EPS guidance of 2.480-2.530 for the period, compared to the consensus estimate of 2.280. The company also...
MarketBeat·13d ago
News Placeholder
Summit Creek Advisors LLC Has $13.98 Million Position in LeMaitre Vascular, Inc. $LMAT
Summit Creek Advisors LLC decreased its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 4.2% in the second quarter, according to the company in its most recent filing with the...
MarketBeat·13d ago
News Placeholder
LeMaitre Vascular (LMAT) Q3 Earnings Surpass Estimates
LeMaitre (LMAT) delivered earnings and revenue surprises of +8.77% and -2.03%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago

Latest LMAT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.